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Summary
 
L-selectin, an adhesion molecule constitutively expressed on leukocytes, is important for pri-
mary adhesion and extravasation of lymphocytes at specialized high endothelial venules within
lymph nodes and other leukocytes at sites of inflammation. We have generated L-selectin–defi-
cient mice by targeted disruption, and have confirmed a previously reported phenotype which
includes strikingly impaired contact hypersensitivity (CHS) responses to reactive haptens (Ted-
der, T.F., D.A. Steeber, and P. Pizcueta. 1995. 
 
J. Exp. Med.
 
 181:2259–2264; Xu, J.C., I.S.
Grewal, G.P. Geba, and R.A. Flavell. 1996. 183:589–598.). Since the mechanism of this im-
pairment has not been clarified, we sought to define the stage(s) at which the CHS response is
affected in L-selectin–deficient mice. We show that epidermal Langerhans cells in L-selectin–
deficient mice are normal in number, migrate to peripheral lymph nodes appropriately, and
are functional in presenting allogeneic and haptenic antigens. Moreover, T cells, as well as neu-
trophil and monocyte effector populations, are fully capable of entry into the inflamed skin sites
in the absence of L-selectin. Thus, antigen presentation and effector mechanisms are intact in
L-selectin deficient mice. In contrast, virtually no antigen-specific T cells can be found within
draining peripheral nodes after a contact challenge, suggesting that the defect resides primarily
in the inability of antigen-specific T cells to home to and be activated in these nodes. Indeed,
L-selectin–deficient mice mount completely normal CHS responses when alternate routes of
immunization are used. These studies pinpoint the lesion in CHS to a discrete stage of the af-
ferent limb of the response, clarify the role of L-selectin on effector populations, and illustrate
the critical importance of the route of antigen entry to the successful execution of an immune
response.
 
T
 
o access antigen within the tissues and to maintain ef-
fective immune surveillance, lymphocytes must first
 
traverse the vascular barrier and then continuously recircu-
late from the blood to organized lymphoid and extra-lym-
phoid sites (1). This tissue-specific traffic is regulated in part
by the interaction between adhesion receptors on the sur-
face of lymphocytes called homing receptors and their ligands
on specialized postcapillary endothelial cells (2). L-selectin
is expressed on T cells, B cells, neutrophils, and monocytes.
All three selectins, including endothelial E- and P-selectin,
mediate the repeated transient primary adhesion of leuko-
cytes, termed rolling, to vascular endothelium via interac-
tions between their Ca
 
2
 
1
 
-dependent lectin domains and
their respective carbohydrate ligands (3). Subsequent firm
adhesion is primarily mediated by integrin molecules and
their ligands, both members of the immunoglobulin super-
family. In combination, the sequential participation of these
adhesion families provides much of the information re-
quired for site-specific leukocyte trafficking (4, 5).
L-selectin was first identified as the peripheral lymph
node (PLN)
 
1
 
 specific homing receptor in mice (2, 6, 7),
and has been shown to be important both for the homing
of lymphocytes to PLN and traffic of other leukocytes to
sites of inflammation. Naive lymphocytes exit the blood via
morphologically distinct postcapillary high endothelial venules
in lymph nodes and other secondary lymphoid organs (1,
 
1
 
Abbreviations used in this paper:
 
 CHS, contact hypersensitivity; DNBS,
2,4-dinitrobenzene sulfonic acid; DNFB, 2,4-dinitrofluorobenzene; DTH,
delayed-type hypersensitivity; ES, embryonic stem; LC, Langerhans cells;
MLN, mesenteric lymph node; oxazolone, 2-phenyl-4-ethoxymethylene
oxazolone; PGKneo, phosphoglycerate kinase promoter/neomycin resis-
tance gene; PLN, peripheral lymph node; PNAd, peripheral node ad-
dressin; TNBS, trinitrobenzene sulfonic acid.
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8). While much evidence has supported the role of L-selec-
tin in lymphocyte homing to lymph nodes, perhaps most
compelling has been the development of L-selectin–defi-
cient mice, which, as demonstrated here and previously (9,
10), results in PLN strikingly diminished in size and exten-
sively lymphocyte-depleted.
With these mice, we have begun to investigate the role
of L-selectin in the development of an immune response
using contact hypersensitivity (CHS) as an experimental
model of delayed-type hypersensitivity (DTH). The ability
to obtain a measurable reaction to a contact allergen is de-
pendent on a distinct pathway whose interruption at any of
the following steps may cause an impaired response. (
 
a
 
)
Epidermal Langerhans cells (LC), MHC class II bearing
dendritic cells of the skin, are the major antigen presenting
cells within the skin, and have been shown to be required
for the initiation of contact sensitization (11, 12). Thus, the
absence of LC, their lack of migration into lymph nodes,
and/or their inability to function in antigen presentation,
could result in an impaired response. (
 
b
 
) Circulating naive
T cells may fail to exit the vasculature into PLN, prevent-
ing antigen encounter. (
 
c
 
) T cell activation within lymph
nodes may not occur. (
 
d
 
) Impaired T cell traffic to the
challenged skin site may subvert a response. Lastly (
 
e
 
), the
ability of nonspecific effector cells to migrate to and enter
the inflamed site may be abrogated. Thus, this antigen-spe-
cific inflammatory pathway engages in a defined sequence
all of the hematolymphoid elements which express L-selec-
tin, and provides the opportunity to determine at which
juncture(s) the lack of L-selectin impacts the response.
We demonstrate here that the antigen presentation path-
way and effector functions are intact in L-selectin–deficient
mice and that the major defect in responsiveness is due to
the lack of T cell sensitization in draining PLN. These re-
sults further our understanding of the important role of
L-selectin in lymphocyte homing and thus the develop-
ment of PLN, the consequences of its absence for the gen-
eration of primary immune responses, and the essential role
of these secondary lymphoid organs in mounting responses
to contact challenges.
 
Materials and Methods
 
Reagents and Antibodies.
 
Benzylkonium chloride, croton oil,
Con A, 2,4-dinitrofluorobenzene (DNFB), 2,4-dinitrobenzyl sul-
fonic acid (DNBS), trinitrobenzyl sulfonic acid (TNBS), 2-phe-
nyl-4-ethoxymethylene oxazolone (oxazolone), and FITC were
purchased from Sigma Chem. Co. (St. Louis, MO). PMA and
geneticin were obtained from GIBCO BRL (Gaithersburg, MD),
ionomycin from Calbiochem Corp. (La Jolla, CA), and GM-CSF
from GIBCO BRL (Gaithersburg, MD). Gancyclovir was ob-
tained from Roche BioScience. (Palo Alto, CA). The following
anti–mouse antibodies were used for FACS
 
Ò
 
 analysis and immu-
nohistochemistry: anti-CD4, anti-CD8
 
a
 
 (GIBCO BRL); anti-
CD3
 
e
 
, anti-I-A
 
b
 
, anti-GR-1, anti-CD8, anti-CD11b, anti-B220,
anti-TNP (hamster anti–mouse isotype control) (PharMingen,
San Diego, CA); anti-Thy1.2 (Becton Dickinson Co., San Jose,
CA); anti-I-A (anti-I-A
 
b,d,q
 
 and I-E
 
d,k
 
,
 
 
 
M5/114.15.2, American
Type Culture Collection, Rockville, MD), and anti-Mac-1 (M1/
70)  (13) (American Type Culture Collection); anti-F4/80 (13)
(American Type Culture collection); and anti–L-selectin, MEL-
14 (2). The following secondary reagents were used when appli-
cable: fluorescein-conjugated goat anti–rat immunoglobulin (goat
anti–rat Ig-FITC), goat anti–mouse immunoglobulin-FITC, strep-
tavidin–PE (CALTAG Labs., San Francisco, CA), and goat anti–
rabbit IgG (Jackson ImmunoResearch Labs., Inc., West Grove, PA).
 
Generation of L-selectin Mutant Mice.
 
Transfection of embry-
onic stem (ES) cells was done using 100 
 
m
 
g of linearized targeting
vector DNA into 10
 
7
 
 J1 cells (gift of R. Jaenish, Massachusetts In-
stitute of Technology, Cambridge, MA) or AB1 cells (gift of A.
Bradley, Baylor College, Houston, TX), and grown in 250 
 
m
 
g/ml
active Geneticin and 2 
 
m
 
m gancyclovir. Primary analysis of clones
was done by Southern hybridization with probes both 5
 
9
 
 and 3
 
9
 
of the targeting vector. Correctly targeted J1 or AB1 ES cells
with normal karyotypes were injected into C57BL/6J blastocysts
and transferred to pseudopregnant females. Chimeras from one J1
and one AB1 clone were mated to C57BL/6J animals. Agouti
offspring were typed by Southern hybridization of tail DNA for
the mutant L-selectin allele (see Fig. 1 
 
B
 
). L-selectin heterozy-
gous mice derived from one J1 and one AB1 clone were sepa-
rately intercrossed to obtain two independent homozygous L-selec-
tin–deficient mouse lines. There was no difference in phenotype
between J1- and AB1-derived mice, and the former were gener-
ally used for these studies.
 
CHS Responses.
 
CHS responses were induced using the anti-
gen DNFB as previously described (11, 15). 25 
 
m
 
l of 0.5% DNFB
in 4:1 acetone/olive oil solution was painted on the shaved abdo-
mens of mice on days 0 and 1. Mice were challenged on days 5 or
9 by topical application of 20 
 
m
 
l of 0.2% DNFB (10 
 
m
 
l/side of
the pinna). CHS responses to oxazolone were obtained by apply-
ing 25 
 
m
 
l of a 100 mg/ml solution in 4:1 acetone/olive oil onto
the shaved abdomens on day 0, and then challenging on days 7 or
12 with 10 
 
m
 
l of a 10 mg/ml solution of oxazolone (5 
 
m
 
l/side).
CHS responses to FITC were induced by applying 0.4 ml of
freshly made 5% FITC in 1:1 acetone/dibutylpthalate to the ab-
domen as previously described (16). 6 d later, the CHS reaction
was elicited by applying 10 
 
m
 
l of the FITC solution (5 
 
m
 
l/side). 
For all CHS experiments, baseline ear thickness was deter-
mined with a Fowler caliper (Lux Scientific Instrument Corp.,
Millville, NJ) before sensitization. Ear swelling responses were
measured at 24, 48, or 72 h after elicitation and the change in ear
thickness from baseline measurement was computed. Values re-
ported are at 24 h, unless otherwise indicated. Each ear was mea-
sured five times and the mean of these values was used. Statistical
analysis of the groups was done using the Student’s 
 
t
 
 test and
 
P
 
 values 
 
,
 
0.05 were considered to be statistically significant.
Benzylkonium chloride and croton oil were used to cause non-
specific inflammation as described (17). 10 
 
m
 
l of either 5% ben-
zylkonium chloride or 0.8% croton oil in acetone was painted
onto the pinna. 16 h later, the change in ear thickness from base-
line was measured as described for CHS responses.
 
T Cell Activation Assays.
 
In vitro proliferation to DNBS, the
water soluble analog of DNFB, was carried out as described (15)
with a few modifications. Briefly, inguinal, axillary, and brachial
lymph nodes from either two L-selectin–deficient mice or two
wild-type littermate controls, sensitized on the abdomen with
DNFB 5 d before, were collected and pooled. Spleens and me-
senteric lymph nodes (MLN) were also collected and pooled.
Cells were cultured in the presence or absence of DNBS (50 
 
m
 
g/ml).
Polyclonal activation was accomplished by incubating pooled
PLN cells or spleen cells with 1 ng/ml PMA plus 500 ng/ml Ion-
omycin or with 5 
 
m
 
g/ml of Con A. Proliferation in response to 
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immobilized anti-CD3 was accomplished by incubating 4 
 
3
 
 10
 
4
 
pooled PLN or spleen cells with increasing concentrations of
anti-CD3 or control antibody. All cultures were pulsed with 1 
 
m
 
Ci/
well of [
 
3
 
H]thymidine for 18 h.
 
Purification of Draining Langerhans Cells.
 
I-A
 
1
 
 LC from PLN
were purified as described (18). 24 h after application of hapten
(DNFB or FITC) to the abdomens of mice, pooled inguinal, ax-
illary, and brachial lymph nodes were homogenized, filtered
through nylon mesh, and washed in RPMI 1640/10% FCS. 4 ml
of a cell suspension containing either 5 
 
3
 
 10
 
6
 
 wild-type cells or
1 
 
3
 
 10
 
6
 
 L-selectin–deficient cells were layered onto 2 ml of me-
trizamide (14.5 g/100 ml of medium; Sigma Chemical Co.).
Cells were centrifuged at 600 
 
3
 
 
 
g
 
 for 10 min at room tempera-
ture, and the cells at the interface were collected.
 
In Vitro Antigen Presentation Assays.
 
Allogeneic mixed lym-
phocyte reactions were performed as described (19). Stimulator
cells were LC purified from draining lymph nodes and irradiated
with 2,000 RADS. Responder cells were either BALB/c or
C57BL/6J nylon wool–purified splenic T cells (20). To remove
residual dendritic cells, B cells, and macrophages from responder
cell populations, T cell preparations were incubated with anti-I-A
for 40 min and lysed in baby rabbit complement (Pel-Freeze
Biologicals, Rogers, AZ) for 40 min. 98% of responder cells were
T cells by FACS
 
Ò
 
 analysis with anti-Thy1.2-FITC. 2 
 
3
 
 10
 
5
 
 re-
sponder T cells were incubated with varying concentrations of ir-
radiated LC for 24 h.
For antigen-specific proliferation assays, antigen pulsing was
performed by incubation of naive PLN cells with 25 mM DNBS
in PBS for 25 min at 37
 
8
 
C, followed by irradiation (2,000
RADS). 25,000 irradiated PLN cells were incubated with in-
creasing numbers of T cells from wild-type mice sensitized 5 d
before with DNFB. Proliferation for both assays was measured by
[
 
3
 
H]thymidine uptake as described above.
 
Immunohistochemistry.
 
Ears were severed from mice, embed-
ded in OCT compound, and frozen. Serial cryostat sections were
fixed in methanol and stained with the following antibodies: GR-1,
Mac-1, CD4, CD8, B220, Thy1.2, and MEL-14. Sections were
rinsed with PBS and biotinylated secondary antibody and/or strep-
tavidin horseradish peroxidase was added. 1X DAB (0.5 
 
m
 
g/ml
diaminobenzidene) and 0.03% H
 
2
 
O
 
2
 
 in 50 mM Tris was added
for 10 min, slides were washed in PBS/0.5% CuSO
 
4
 
, and coun-
terstained with methylene blue.
 
Adoptive Transfer and Delayed-Type Hypersensitivity with Hapte-
nated Spleen Cells.
 
Adoptive transfer of wild-type T cells to na-
ive mice was performed as described (21) with minor modifica-
tions. PLN cells from wild-type mice sensitized 5 d before with
25 
 
m
 
l of DNFB or from control untreated mice were harvested,
depleted of macrophages and B cells using biotinylated anti-Mac-1
and anti-B220 followed by streptavidin-conjugated magnetic
beads (DYNAL Inc., Lake Success, NY). 2 
 
3
 
 10
 
7
 
 T cells (98%
pure by FACS
 
Ò
 
) were injected intravenously into wild-type or
L-selectin–deficient mice. 12 h later, mice were elicited with
DNFB and 24 h ear swelling responses were measured.
Splenic dendritic cells were prepared as described (22), with
minor modifications. Splenocytes were plated and incubated at
37
 
8
 
C for 90 min. Nonadherent cells were removed and GM-CSF
was added at 10 ng/ml to the adherent cells. Cells released after
overnight incubation in GM-CSF were used as splenic dendritic cell
preparations. These were haptenated by incubation with 25 mM
DNBS as described above. For intravenous and subcutaneous im-
munizations, 1 
 
3
 
 10
 
6
 
 DNBS-treated purified splenic dendritic
cells or 2 
 
3
 
 10
 
7
 
 splenocytes were injected into naive L-selectin–
deficient or wild-type littermate control mice. Control groups re-
ceived uncoupled cells for both injection routes. For elicitation,
mice were challenged with 0.25% of DNFB on the left pinna (10 
 
m
 
l)
5 d after cell injection.
 
Results
 
Generation of L-selectin–deficient Mice.
 
Mice disrupted at
the L-selectin locus were created using the techniques of
homologous recombination in ES cells (23, 24). A fragment
of the L-selectin genomic DNA containing exons 2–6 was
used to construct a replacement vector, and exon 3, encod-
ing the lectin domain, was chosen for disruption (Fig. 1 
 
A
 
).
Phosphoglycerate kinase promotor/neomycin resistance
gene (PGKneo) was inserted into the BglII site of the lectin
domain in the same transcriptional orientation as L-selec-
tin. Targeting vector DNA was introduced into ES cells
and recombinant ES clones were injected into blastocysts
of C57Bl/6 mice. Resulting male chimeras were crossed to
C57Bl/6 females, germline transmission was confirmed by
Southern blotting, and heterozygous animals were mated
to obtain mice homozygous for the mutation (Fig. 1 
 
B
 
).
L-selectin expression on leukocytes is absent in L-selec-
tin mutant mice, and Northern analysis showed no tran-
Figure 1. Generation and characterization of L-selectin deficient mice.
(A)The neomycin resistance gene driven by the PGK promoter was in-
serted into the lectin domain, exon 3, of a targeting vector containing
6.5 kb of L-selectin genomic DNA. The HSV-thymidine kinase gene was
added to the 39 end of the replacement vector as a negative selection
marker. (B) Southern hybridization of L-selectin–deficient mouse DNA
shows only the mutated L-selectin allele. Mouse-tail DNA was digested
with BglII and hybridized with a radiolabeled intron-1 probe. Only the
mutant 4.8-kb allele is present in the homozygous L-selectin–deficient
mouse (*). Both the mutant 4.8-kb and the germline 2.8-kb allele are
present in the heterozygous mouse. (C) Peripheral nodes (inguinal, bra-
chial, and axillary) were excised from L-selectin–deficient, heterozygous,
and wild-type littermate mice and weighed. Both L-selectin wild-type
and heterozygous mice have significantly increased weights over L-selec-
tin mutant animals (n 5 9; P ,0.05). (D) Primary adhesion of L-selectin–
deficient, heterozygous mutant, and wild-type spleen cells to PNAd. Cells
were analyzed under shear stress in coated glass capillary tubes at 2.1
dynes/cm2 (40). Wild-type mice have signifcantly greater numbers of
splenocytes rolling on PNAd-coated surfaces than either heterozygous or
homozygous L-selectin–deficient mice (P ,0.05). 
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script when probed with full-length L-selectin cDNA (data
not shown). The general features of these mice are substan-
tially in agreement with those reported by Arbones et al.
(10). The striking anatomic defect is the dramatic decrease
in weight of PLNs (Fig. 1 
 
C
 
), which are characterized by
abnormal architecture, with no distinction of cortical and
medullary regions and no B cell follicles. Although lym-
phocyte numbers in the mutant nodes are decreased almost
90%, cell surface analysis reveals no difference in the per-
centages of CD4 T cells, CD8 T cells, or B cells compared to
wild-type mice. L-selectin deficient spleens were signifi-
cantly increased (30%) in size over wild type, accompanied
by a 25% increase in T cells, presumably due to the dis-
placement of T cells from lymph nodes to spleen. Func-
tionally, L-selectin–deficient leukocytes failed to exhibit rol-
ling on the major high endothelial venules borne L-selectin
ligand, peripheral node addressin (PNAd), in an in vitro
flow assay (Fig. 1 
 
D
 
). Cells from heterozygous animals ex-
hibited 
 
z
 
50% of the level of rolling of wild-type cells, cor-
relating with surface L-selectin expression levels.
 
L-selectin–deficient Mice Exhibit Impaired CHS Responses.
 
Because of the multiple sites at which L-selectin can con-
tribute, CHS responses were used to examine the func-
tional significance of the loss of L-selectin expression. These
mice show markedly impaired CHS responses to each of
the tested haptens DNFB, oxazolone, and FITC (Fig. 2 
 
A
 
).
It is also of interest that the response of sensitized heterozy-
gous mice to DNFB was not significantly different from
the response of wild-type mice (Fig. 2 
 
A
 
), despite less ef-
fective adhesion under shear forces. The extent of ear
swelling is comparable among sensitized mutant mice, non-
sensitized mutant mice, and nonsensitized wild-type mice,
suggesting that no substantial antigen-specific element to
the response was present in L-selectin–deficient mice. In
contrast, while hapten-specific responses are blunted in
L-selectin–deficient mice, the nonspecific irritant response,
different for each hapten, remains intact in mutant animals
(see below). Moreover, the irritant effect is not due to ve-
hicle since both DNFB and oxazolone, each with different
irritant effects, are applied in the same vehicle.
Xu et al. have reported previously that L-selectin–defi-
cient mice exhibit normal CHS responses to oxazolone at 9 d
after sensitization (2). We routinely sensitize with ox-
azolone for 7 d and we see no significant response in our
mutant animals at this time point (Fig. 2 
 
A
 
). In addition,
delaying elicitation until day 12 also had no effect on the
unresponsiveness of L-selectin–deficient mice (Fig. 2 
 
B).
To further examine whether the kinetics of ear swelling af-
ter challenge were altered, animals were sensitized with
DNFB and elicited 9 d after priming (Fig. 2 B). No re-
sponse was induced at this time point, whether measure-
ments were taken at 24, 48, or 72 h after elicitation. There-
fore, it is clear that the duration of unresponsiveness is
long-lasting under our conditions.
Langerhans Cells in L-selectin–deficient Mice Are Present,
Traffic Normally, and Present Antigen. It is known that LC
are bone marrow derived (25) and that L-selectin is ex-
pressed on bone marrow progenitors (26). Therefore, their
development and/or homing to skin may be impaired in
these mice. Fig. 3 A shows a representative whole mount
of abdominal skin from an L-selectin–deficient and wild-
type mouse stained with anti-I-A. Comparison of L-selec-
tin mutant mice and wild-type littermate controls showed
that there was no difference in the density, morphology, or
distribution of these cells. The average number of I-A1
epidermal cells in L-selectin–deficient mice was 1,050 6
Figure 2. (A) L-selectin–deficient mice have impaired CHS responses
to DNFB, oxazolone, and FITC. Wild-type mice sensitized and elicited
had significantly greater ear swelling than the sensitized and elicited L-selec-
tin–deficient mice (*; P ,0.05) and significantly greater ear swelling than
both wild-type and L-selectin–deficient elicited-only mice (*; P ,0.05).
There was no significant difference between the response of L-selectin–
deficient mice which were both sensitized and elicited, and either wild-
type or L-selectin–deficient mice which were elicited only for any of the
tested haptens (P .0.5). Results shown are the change in ear thickness at 24 h
from mice elicited with CHS reagent on days 5 (DNFB), 6 (FITC), or 7
(oxazolone). n values are given in parentheses. (B) Delay of challenge
with either DNFB or oxazolone does not restore the ability of L-selectin–
deficient mice to respond to CHS agents. Wild-type mice sensitized and
elicited had significantly greater ear swelling than the sensitized and elic-
ited L-selectin–deficient mice when mice were challenged 9 d after sensi-
tization for DNFB or 12 d after sensitization for oxazolone (*; P ,0.05).
There was no significant difference between the response of sensitized
and elicited L-selectin–deficient mice and mice which were elicited only
(P .0.5).2345 Catalina et al.
180/mm2 compared to 1,080 6 160 /mm2 in wild-type
mice. Thus, LC are present in normal densities in these L-selec-
tin–deficient mice. In addition, no differences were noted
in Thy-11 dendritic epidermal T cells (data not shown).
To study whether antigen–bearing LC traffic from the
skin to lymph node appropriately in L-selectin–deficient
animals, the contact sensitizing reagent FITC was used. It
has previously been shown that the FITC1/I-A1 cells in
the draining nodes 24 h after skin painting are predomi-
nantly LC which have migrated from the skin (18). Fig. 3 B
shows that in both the L-selectin–deficient animals and
wild-type controls about 25% of the metrizamide-enriched
dendritic cell population were FITC1/I-A1. These cells
did not stain with antibodies to murine CD3-e, B220, or
to the F4/80 macrophage marker, consistent with their
dendritic cell origin. Furthermore, analysis of metrizamide
purified dendritic cells from the spleen (Fig. 3 B) and MLN
(not shown) revealed that LC do not migrate to other sec-
ondary lymphoid tissues (,0.4% FITC1/I-A1). These re-
sults indicate that antigen painted on the epidermis of L-selec-
tin mutant mice is taken up by I-A1 APCs which then
migrate in normal numbers to PLN, but not other second-
ary lymphoid tissues.
To determine whether LC in the L-selectin mutant mice
are functionally active, dendritic cells from draining lymph
nodes of hapten sensitized mice were purified and exam-
ined for their capacity to activate allogeneic T cells. Isolated
allogeneic BALB/c (H-2d) or syngeneic C57BL/6J (H-2b)
T cells were mixed with either wild-type or L-selectin–
deficient irradiated dendritic cells (H-2b) (Fig. 3 C). Den-
Figure 3. L-selectin–deficient
mice have an intact antigen pre-
sentation pathway. (A) Epider-
mal whole mounts from L-selec-
tin–deficient mice show normal
numbers and distribution of LC.
Whole mounts of abdominal
skin were prepared and stained
with anti-I-Ab (41). I-A1 cells
were counted in 30 fields/slide
(field  5 0.1 mm2), and calculated
as the average of cells/mm2 over
two slides. (B) LC are present in
L-selectin–deficient mice and
drain to PLN following skin
painting with FITC. Mice were
sensitized with FITC and 24 h
later PLN and spleens were col-
lected and centrifuged over me-
trizamide gradients (18). Cells at
the interface were collected and
stained with biotinylated anti–
mouse I-A followed by streptavi-
din-PE and analyzed by two-
color FACSÒ analysis to detect
the presence of draining I-A1/
FITC1 LC. One of six represen-
tative experiments is shown. (C)
LC from L-selectin–deficient mice can initiate allogeneic responses. LC collected from PLN of FITC-painted wild-type (squares) or L-selectin–deficient
mice (triangles) were irradiated and incubated for 48 h with 2 3 105 T cells from either BALB/c (allogeneic; open squares and triangles) or C57BL/6J (syn-
geneic; closed squares and triangles) mice. Cultures were pulsed with [3H]thymidine for 18 h before harvesting. (D) LC can initiate antigen-specific re-
sponses. Irradiated PLN cells were used as APCs from wild-type or L-selectin–deficient mice, and were either pulsed with or without DNBS. These cells
were incubated for 48 h with increasing concentrations of PLN T cells isolated from wild-type mice sensitized with DNFB 5 d before. Cultures were
pulsed with [3H]thymidine for 18 h before harvesting.2346 Contact Hypersensitivity Responses in L-selectin–deficient Mice
dritic cells isolated from L-selectin–deficient mice were as
potent as those from wild-type controls in stimulating alloge-
neic T cells. Furthermore, to examine presentation of a con-
ventional antigen, dendritic cells from both wild-type and
L-selectin–deficient mice were conjugated to DNBS to
serve as APCs, irradiated, and incubated with purified T cells
from wild-type mice sensitized with DNFB. L-selectin–
deficient cells were as competent at stimulating antigen-
specific proliferation of T cells as wild-type cells (Fig. 3 D).
These results indicate that LC in L-selectin deficient mice
are functionally active.
L-selectin–deficient Mice Do Not Develop Antigen-Specific
T Cells in Response to a CHS Challenge. We next tested if
there was altered T cell responsiveness in L-selectin–defi-
cient mice. A T cell defect could be due either to a failure
of T cells to be stimulated in lymph nodes in the afferent
limb, or an inability of antigen-specific T cells to traffic to
the inflammatory site in the efferent limb. To test the
former, antigen-specific responses in draining lymph nodes
were examined (15). L-selectin–deficient or wild-type ani-
mals were painted with DNFB and 5 d later, lymph nodes
were removed and incubated in vitro with DNBS. Fig. 4 A
shows that proliferation of L-selectin–deficient lymph node
T cells in response to DNBS is decreased 97% compared to
wild-type lymph node T cells, indicating a profound deficit
in antigen-specific T cells in PLN.
Because L-selectin–deficient mice have compensatory T
cell traffic to the spleen, it was possible that other secondary
lymphoid organs provided alternative sites for T cell stimu-
lation. Although low but detectable stimulation was present
in spleen and MLN from wild-type mice, there was no de-
tectable response in these organs from mutant mice (Fig. 4 A).
This nonresponsiveness was still demonstrable when spleen,
MLN, and PLN were examined 9 d after sensitization.
Thus, DNFB-reactive T cells in normal mice reside over-
whelmingly in PLNs after contact sensitization, and there is
no compensatory shift to other sites in L-selectin–deficient
mice.
To test for an intrinsic signaling defect in L-selectin–defi-
cient lymph node T cells, we examined their capacity to
proliferate in response to polyclonal activation. Fig. 4 B
shows that T cells from L-selectin–deficient mouse lymph
nodes proliferated comparably to wild-type animals in re-
sponse to stimulation by PMA 1 Ionomycin, Con A, or
immobilized CD3 mAb, suggesting that pathways of T cell
activation in vitro are intact in L-selectin–deficient lymph
node T cells.
Adoptive Transfer of Sensitized Normal T Lymphocytes into
L-selectin–deficient Mice Restores the Ability to Respond to a
CHS Agent. The actual ear swelling component of CHS
is thought to be initiated by antigen-specific T cells fol-
lowed by the recruitment of nonspecific effector cells (27).
To examine the efferent limb of the response, we trans-
ferred 2 3 107 lymph node T cells purified from wild-type
mice sensitized 5 d earlier with DNFB intravenously into
either L-selectin–deficient or wild-type littermate control
mice, which were challenged on the ear 12 h later with
DNFB. Responses were measured 24 h later. Fig. 5 shows
there is no significant difference between the response of
wild-type and L-selectin–deficient mice when sensitized
wild-type T cells are transferred. Furthermore, not only is
ear swelling restored, but the nonspecific effector cells,
which lack L-selectin, are effectively recruited into the elici-
tation site. Quantitative analysis with GR-1, Mac-1, and
T cell markers revealed infiltrates which were indistinguish-
able between wild-type and L-selectin–deficient mice (Ta-
ble 1). This demonstrates that sensitized T cells are suffi-
cient to obtain an ear swelling response in mutant mice,
that there are no other local defects in L-selectin–deficient
mice precluding a normal response, and that nonlymphoid
effector cell trafficking is appropriate.
L-selectin–deficient Mice Develop CHS When Antigen Is Ad-
ministered By Alternate Routes. If the defect in L-selectin–
deficient mice is solely that mutant lymphocytes cannot
home to PLNs for sensitization, then immunization via
routes which allow sensitization at sites other than PLN
Figure 4. L-selectin–deficient mice have markedly diminished sensi-
tized T cells after skin painting with DNFB. (A) Cells from mice sensi-
tized 5 d earlier with DNFB were cultured for 36 h in the presence of
DNBS after which cultures were pulsed with [3H]thymidine for 18 h.
Each point represents the average of three separate mouse groups, each
group consisting of pooled organs from two mice. Each group was done
in triplicate. Background proliferation, detected by incubation of the cells
in the absence of DNBS, was subtracted. (B) Resident T cells from L-selec-
tin–deficient lymph nodes are able to respond normally to in vitro stimuli.
PLN were incubated with PMA plus Ionomycin, Con A, or immobilized
anti-CD3 or hamster IgG control antibody. Cells were cultured in tripli-
cate for 36 h and then pulsed with [3H]thymidine for 18 h.2347 Catalina et al.
should permit the development of an immune response.
Splenic dendritic cells from L-selectin–deficient or wild-
type animals were therefore conjugated with DNBS and
injected intravenously or subcutaneously into mutant or
wild-type animals. Figs. 6, A and B, show that L-selectin–
deficient, antigen-pulsed splenic dendritic cells delivered by
either route result in an ear swelling response in mutant
mice equivalent to wild type. To determine where anti-
gen-reactive T cells resided, in vitro T cell proliferative re-
sponses to hapten, measured 5 d following subcutaneous
injection of L-selectin–deficient antigen-pulsed splenic den-
dritic cells, were performed. Proliferation was substantial
in T cell splenic cultures from L-selectin–deficient mice
(6,869 6 630 cpm), but was essentially background in
lymph node T cells (125 6 100 cpm). In contrast, in wild-
type mice, proliferative activity occurred primarily in the
lymph node cells (7,800 6 721 cpm), and, to a lesser ex-
tent, in spleen (2,445 6 202 cpm) after subcutaneous injec-
tion. Thus, antigen-specific proliferation of splenic, but not
lymph node, T cells from L-selectin–deficient mice was ev-
ident, even after subcutaneous immunization where sensiti-
zation normally proceeds via draining lymph nodes. These
results suggest that the entire pathway of DTH is intact
when the peripheral node dependence of the response is
removed.
Immunohistochemical analysis of elicited ears confirms
the comparable infiltrates of T cells as well as granulocytes
and monocytes in L-selectin–deficient and control animals
(Fig. 6 C, Table 1), indicating that L-selectin–deficient T cells
are competent in responding to antigen and trafficking to
the challenged skin site. These results also demonstrate that
L-selectin–deficient dendritic cells are equally effective at
sensitizing wild-type mice to DNFB as wild-type dendritic
cells. Therefore, the results reinforce the observation that
there is no defect in the ability of L-selectin–deficient T
cells, neutrophils, or monocytes to enter the inflamed ear
(Table 1), and that antigen presentation is intact.
L-selectin–deficient Mice Have a Normal Acute Response to Ir-
ritants. We have shown that when primed T cells are sup-
plied, L-selectin–deficient mice support the full develop-
ment of a CHS response, including the recruitment of
L-selectin negative nonspecific effector cells. We chose to
induce an acute response to evaluate the nonspecific effec-
tor arm in isolation. Mice were painted with a solution of
the irritants 0.8% croton oil or 5% benzylkonium chloride,
and the change in ear thickness was measured 16 h after ap-
plication. Fig. 7 shows that there was no significant differ-
ence in the ear swelling between L-selectin–deficient and
wild-type mice. Additionally, ears were embedded, sec-
tioned, and analyzed with antibodies to GR-1, Mac-1,
CD4, CD8, Thy1.2, and B220. Immunohistologic analysis
revealed infiltrates consisting of macrophages and granulo-
Figure 5. Adoptive transfer of wild-type sensitized T cells into L-selec-
tin–deficient mice restores their ability to mount CHS responses. 2 3 107
T cells from wild-type mice sensitized with DNFB were harvested and
injected into either wild-type or L-selectin–deficient mice. When mice
were elicited 12 h later, there was no significant difference between the
24 h ear swelling response of L-selectin–deficient mice as compared to
wild-type littermate controls (P .0.5). Both had significantly greater re-
sponses than animals injected with PLN cells from unsensitized mice
(*, P ,0.05).
Table 1. Immunohistochemical Characterization of Cellular Infiltrates in Ears Following Topical Challenge
Mice Cell type‡
T cell adoptive transfer* S.C. immunization* Nonspecific irritant*
Sensitized Nonsensitized Sensitized Nonsensitized Sensitized Nonsensitized
1/1 Mac/Gran 527 6 124§ 33 6 26 553 6 120 19 6 25 3,535 6 950 100 6 25
2/2 Mac/Gran 572 6 142 15 6 24 540 6 143 18 6 21 3,375 6 117 236 6 120
1/1 Gran 150 6 95 18 6 21 252 6 153 18 6 25 3,467 6 96 335 6 12
2/2 Gran 276 6 141 20 6 20 265 6 101 17 6 19 3,507 6 95 184 6 57
1/1 T cells 107 6 59 7 6 6 121 6 43 25 6 25 0 i
2/2 T cells 91 6 37 12 6 4 119 6 41 29 6 27 0 i
*T cell Adoptive Transfer: purified 1/1 PLN T cells from DNFB-sensitized or control mice were injected intravenously into 1/1 and 2/2 mice.
Responses were elicited with DNFB 12 h after cell injection. S.C. Immunization: DNBS-treated or control 2/2 spleen cells were injected subcuta-
neously on the dorsum 1/1 and 2/2 mice. Responses were elicited with DNFB 5 d after cell injection. Nonspecific Irritant: 10 ml of 0.8% croton oil
was painted onto the pinna of 1/1 and 2/2 mice. Ears were harvested 24 h following DNFB challenge or 16 h following application of croton oil,
embedded, and stained.
‡Mac/Gran: macrophages plus granulocytes, anti-Mac-1. Gran: granulocytes only, anti–GR-1. T cells, anti-Th1.2.
§Cells/mm2.
iNot done.2348 Contact Hypersensitivity Responses in L-selectin–deficient Mice
cytes but no T or B cells (Table 1). In addition, there was
no significant difference in the density of granulocytes in
L-selectin–deficient animals compared to wild type. In con-
trast to the DNFB specific response, the infiltrate in this non-
specific response was overwhelmingly neutrophils (GR-11)
and not monocytes (Table 1). Therefore, an antigen-inde-
pendent inflammatory response can be mounted normally
in L-selectin deficient mice, and can occur without initia-
tion by T cells.
Discussion
During a CHS response, L-selectin may be necessary at
any or all stages, explaining impaired CHS responses in
L-selectin–deficient mice. Therefore, we have evaluated
these stages systematically. Since it is expressed on most
bone marrow–derived mature and progenitor cell types,
L-selectin could be involved in either the development or
migration of antigen presenting cells. However, L-selectin–
deficient mice have a completely intact antigen presenta-
tion pathway (Figs. 3, A–D). In addition, our results also
emphasize that CHS responses are unique in that they ab-
solutely rely on LC and their migration to draining periph-
eral nodes. We did not observe migration of LC to spleen
(Fig. 3 B) or MLN, even 96 h after topical application of
FITC (data not shown). In contrast, administration of anti-
gen by intravenous or subcutaneous routes resulted in
completely normal CHS responses (Fig. 6). Thus, since
CHS does not support systemic distribution of antigen, a
topical route of antigen entry allows an isolated assessment
of the impact of PLN in L-selectin–deficient mice.
The ability to respond specifically to all reactive haptens
tested after cutaneous sensitization is severely impaired in
L-selectin–deficient mice (Fig. 2 A). However, since base-
line irritant swelling was unaffected, the data suggested that
there was a defect at the level of the antigen-specific T cell.
PLN in L-selectin mice are small, but have normal ratios of
CD4 and CD8 T cells and B cells. Since there is a clear lack
of T cell sensitization in PLN (Fig. 4 A), the resident lym-
phocyte population in these nodes is either quantitatively
Figure 6. L-selectin–deficient mice develop CHS responses when
sensitized via an alternative route. (A) Ear swelling responses 5 d after in-
travenous injection of DNBS-conjugated splenic dendritic cells and chal-
lenge with DNFB were not significantly different between L-selectin–
deficient and wild-type littermate recipients irrespective of the source of
donor cells. Responses were significantly different from those of mice in-
jected with splenic dendritic cells not conjugated to DNBS (*, P ,0.05).
(B) Ear swelling responses 5 d after subcutaneous injection of DNBS-con-
jugated spleen cells and challenge with DNFB were not significantly dif-
ferent between L-selectin–deficient and wild-type littermate recipients
(P .0.5), but were significantly different from mice injected with spleen
cells not conjugated to DNBS (*, P ,0.05). (C) Immunohistochemical
staining of ear sections with anti-Mac-1 and anti-Thy1.2, shows that both
L-selectin–deficient mice and wild-type mice injected subcutaneously
with L-selectin–deficient DNP-conjugated spleen cells and elicited with
DNFB, have similar numbers of infiltrating macrophages and T cells. Ar-
rows indicate representative stained cells. Control mice were injected
subcutaneously with L-selectin–deficient spleen cells not conjugated to
DNBS (3400). Cells stained brown are positive for that marker.2349 Catalina et al.
or qualitatively inadequate for CHS immune responses, and
traffic of T cells to the nodes is apparently so limited as to
preclude recruitment of sufficient additional cells to initiate
a response. These results emphasize (a) the extreme depen-
dence which lymphocyte homing to peripheral nodes has
on the lymph node homing receptor, L-selectin, (b) that
significant compensatory mechanisms for this function do
not exist, and (c) the vital role which PLN play in a contact
response, since in the absence of functional peripheral
nodes, alternative pathways to sensitization are not in-
voked.
It has been shown that activation of naive T cells is ac-
companied by the downregulation or shedding of L-selec-
tin in conjunction with increased levels of other activation
and adhesion markers (28, 29). Therefore, loss of L-selectin
after activation has been thought to aid in the diversion of
lymphocytes from secondary lymphoid organs to effector
sites. We demonstrate that L-selectin is indeed unnecessary
for activated T cells to enter a site of inflamed skin; when
priming is performed intravenously or subcutaneously,
L-selectin–deficient mice can respond with characteristic
DTH and cellular infiltrates, including T cells, indistin-
guishable from wild type (Fig. 6 C, Table 1). It is notewor-
thy that subcutaneous immunization, which generally pro-
ceeds via sensitization in lymph nodes, results in normal
contact responses in these mutant mice. It is clear that LC
migrate normally to lymph nodes in L-selectin–deficient
mice (Fig. 3 B), and we have demonstrated that FITC-
labeled splenic dendritic cells administered subcutaneously
also traffic to PLN similarly to what occurs in wild type
(data not shown). Therefore, antigen traffic appears to pro-
ceed normally after subcutaneous injection. However, the
fact that in vitro antigen proliferation is seen only in spleen
and not lymph nodes in mutant mice suggests that under
the unusual circumstances of these defective nodes, com-
pensatory responsiveness occurs in the spleen. It is possible
that the capacity of lymph nodes to retain APCs is ex-
ceeded with the relatively large numbers of subcutaneously
injected cells compared to topical hapten application, such
that excess cells localize in the spleen. Therefore, it seems
most likely that in the absence of L-selectin, homing and re-
cruitment of antigen-specific T cells, and therefore sensitiza-
tion at PLN sites, is compromised in L-selectin–deficient
mice, and that after subcutaneous immunization, antigen-
reactive cells localize in the spleen, allowing a normal con-
tact response. Finally, whatever other adhesion pathways
are operative, our observations suggest that L-selectin does
not fundamentally influence the entry of activated T cells
into inflammatory sites of the skin.
L-selectin expression on circulating antigen nonspecific
effector populations (i.e., neutrophils and monocytes) has
been suggested to be an important mediator of the primary
adhesion of these cells at sites of inflammation (10, 30–
32). However, the centrality of L-selectin in the trafficking
of monocytes and neutrophils to such sites is complicated
in part by the contributions of the endothelial selectins.
The development of mice disrupted at L-, P-, and/or E-selec-
tin loci has confirmed both the distinct, and sometimes
overlapping, functions of this family in inflammatory pro-
cesses (10, 33–35). Pertinent to work presented here, P-selec-
tin–deficient mice have been shown to have decreased in-
filtrates in CHS (36). Our findings show that neutrophils
and monocytes do not require L-selectin to enter a site of
CHS (Figs. 5 and 6, Table 1), or an inflammatory site even
when the response is not initiated by T cells (Fig. 7). Mice
disrupted at both P- and E-selectin have demonstrated the
importance and interdependence of these molecules in
leukocyte recruitment (35), as these animals are prone to
spontaneous skin infections. L-selectin does not compen-
sate for the absence of endothelial selectins in this skin con-
dition, consistent with our findings. Additionally, since
L-selectin has been suggested to be the ligand for endothe-
lial selectins for human leukocytes (37), if P- and/or E-selec-
tin are important for primary adhesion at sites of CHS in
our mutant animals, L-selectin is not the leukocyte ligand.
Therefore, at least for responses in the skin, L-selectin is
not obligatory for inflammatory cells to gain entry.
The response of our L-selectin–deficient mice to sensiti-
zation with oxazolone differs in some key respects from
that reported by Xu et al. (9). In particular, our studies
show CHS of these mice is severely impaired 24 h after
elicitation compared to wild type, while they see no differ-
ence at 24 h when compared to wild type. Our results are
similar to those reported by Tedder et al. (38). In addition,
Xu et al. (9) reported that increasing the time between sen-
sitization and challenge from 4 to 9 d resulted in restoration
of normal DTH in mutant animals. We see no such induc-
tion of responses at later times to either the identical anti-
gen, oxazolone, or to DNFB (Fig. 2 B). These discrepan-
cies may be reconciled by the fact that Xu et al. (9) used
significantly larger doses (5 3) for elicitation, which may
have resulted in a greater degree of nonspecific inflamma-
tion, and which is unabated in mutant animals at day 9. Al-
ternatively, higher concentrations of antigen may allow
non-LC populations to present antigen (39). Thus, our
findings indicate that absolute responses are dramatically al-
tered from wild type and the failure to induce an antigen-
specific response is quite long lasting.
These studies demonstrate that PLNs which are severely
compromised, as in these L-selectin–deficient mice, can
Figure 7. L-selectin–deficient mice have a normal response to irritants.
Benzylkonium chloride or croton oil was applied to mouse ears, and 16 h
later measurements indicated that the acute, nonspecific ear swelling re-
sponse of L-selectin–deficient mice was not significantly different from
the response of wild-type littermate controls (P .0.5).2350 Contact Hypersensitivity Responses in L-selectin–deficient Mice
have dramatic consequences for the outcome of an im-
mune response. The importance of the classical route of
trafficking naive T cells through PLN is illustrated, as well
as the absolute requirement of these lymphoid organs for
productive immunity in responses which rely on epidermal
LC for antigen presentaion. L-selectin–deficient mice have
intact antigen processing, delivery, and presentation as well
as effector limbs for both lymphoid and nonlymphoid
components, but do not develop sufficient antigen-specific
T cells to mount a response. These observations emphasize
the crucial importance of microenvironmental niches to
the immune system, and the tight regulation of the traffic
of antigen, as well as of leukocytes, which can determine
the fate of an immune response.
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